Skip to main content
You have permission to edit this article.
Edit

Novavax posts first profitable quarter as Covid vaccine rolls out around the world

Novavax reported net income of $203 million in the first quarter, compared to a net loss of $222.7 million the same period last year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.